Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2025-12-24 @ 5:30 PM
NCT ID: NCT02242968
Eligibility Criteria: * INCLUSION CRITERIA: * Age: 18 or older * Available to participate for the planned duration of at least one clinical trial for which screening is being done or to donate blood, nasal swab, throat swab, and/or urine in support of assay development * Able and willing to complete the informed consent process * Agree to have blood and/or urine, stool, nasal swab, or wash samples collected as needed for the clinical trial screening or sample donation process * Agree to participate in procedures, such as electrocardiogram or pulmonary function tests, as may be needed for the clinical trial screening process * Do not have plans to become pregnant while on this study * Able to provide a medical history and other relevant personal information as appropriate EXCLUSION CRITERIA: * A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being * Known to be pregnant or breast-feeding * If planning to enroll in a clinical trial, the receipt of immunoglobulin within the past 6 months or anticipated within the next year * Any other condition that in the opinion of the investigator would make the subject unsuitable for enrollment or could interfere with the subject participating in and completing the study or a specimen donation. * Use of recreational drugs or alcohol dependency or abuse
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 120 Years
Study: NCT02242968
Study Brief:
Protocol Section: NCT02242968